Company Filing History:
Years Active: 2005
Title: Roderick T Bunch: Innovator in Carcinogenesis Biomarkers
Introduction
Roderick T Bunch is a notable inventor based in Mt. Prospect, IL (US). He has made significant contributions to the field of carcinogenesis through his innovative research and patents. His work focuses on biomarkers and assays that are crucial for understanding cancer development.
Latest Patents
Roderick T Bunch holds a patent for "Biomarkers and assays for carcinogenesis." This invention relates to carcinogenesis biomarkers produced by phenobarbital-treated rat hepatocytes. It includes nucleic acid molecules that encode these biomarkers or fragments thereof, as well as nucleic acid molecules that serve as probes or primers for detecting or inducing carcinogenesis. The invention also encompasses applications such as forming antibodies capable of binding to the carcinogenesis biomarkers or their fragments.
Career Highlights
Roderick T Bunch has had a distinguished career, working at G.D. Searle & Company, where he has been able to apply his expertise in the development of innovative solutions in the field of cancer research. His work has contributed to advancements in understanding the mechanisms of carcinogenesis.
Collaborations
Some of Roderick's notable coworkers include Dale Lynn Morris and Sandra W Curtiss. Their collaborative efforts have further enhanced the research and development of biomarkers in the field of carcinogenesis.
Conclusion
Roderick T Bunch's contributions to the field of carcinogenesis through his innovative patents and collaborative work highlight his importance as an inventor. His research continues to pave the way for advancements in cancer detection and treatment.